Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michala E.F. Pedersen et al. JACEP 2016;j.jacep

Published byJasmine Owens Modified over 5 years ago

Similar presentations

Presentation on theme: "Michala E.F. Pedersen et al. JACEP 2016;j.jacep"— Presentation transcript:

1 Michala E.F. Pedersen et al. JACEP 2016;j.jacep.2016.09.016
Protocol for Early Removal of Pericardial Drain Complicating Atrial Fibrillation Catheter Ablation: Patient With Ongoing Bleeding Requiring Continuous Aspiration Needs Acute Referral From the Cardiac Surgeons If it is possible to drain the effusion to dryness, a period of monitoring should ensue. If there is no re-accumulation over a continuous observation period of at least 30 min, our findings suggest that the drain can be safely removed. The cycle may be repeated, but it is recommended that the drain is only removed after a minimum of 30 min to avoid re-accumulation. *Documented on transthoracic echocardiogram. **With prothrombin complex concentrate or Idarucizumab (Boehringer Ingelheim Pharmaceuticals). Michala E.F. Pedersen et al. JACEP 2016;j.jacep American College of Cardiology Foundation

Download ppt "Michala E.F. Pedersen et al. JACEP 2016;j.jacep"

Similar presentations

RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.

RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.
Michala E.F. Pedersen et al. JACEP 2017;3:

Michala E.F. Pedersen et al. JACEP 2017;3:
Oana Dickinson et al. JACEP 2016;2:

Oana Dickinson et al. JACEP 2016;2:
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Suggested approach to patients with dabigatran-associated bleeding

Suggested approach to patients with dabigatran-associated bleeding
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Steven E. Williams et al. JACEP 2015;1:

Steven E. Williams et al. JACEP 2015;1:
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Waddah Maskoun et al. JACEP 2016;2:

Waddah Maskoun et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:
Pablo Ávila et al. JACEP 2015;1:

Pablo Ávila et al. JACEP 2015;1:
Jose C. Pachon M. et al. JACEP 2015;1:

Jose C. Pachon M. et al. JACEP 2015;1:
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:
Kenshi Hayashi et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:
Ashish Shukla et al. JACEP 2015;1:41-51

Ashish Shukla et al. JACEP 2015;1:41-51
Takekuni Hayashi et al. JACEP 2016;2:27-35

Takekuni Hayashi et al. JACEP 2016;2:27-35
Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:
Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;3:

Similar presentations

Ads by Google